These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1622431)

  • 41. Multiple drug resistance.
    Mitscher LA; Pillai SP; Gentry EJ; Shankel DM
    Med Res Rev; 1999 Nov; 19(6):477-96. PubMed ID: 10557366
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combatting Infections with Nanomedicine.
    Fang RH; Zhang L
    Adv Healthc Mater; 2018 Jul; 7(13):e1800392. PubMed ID: 29995335
    [No Abstract]   [Full Text] [Related]  

  • 43. Multiple drug transporters contribute to the brain transfer of levofloxacin.
    Cen Y; Shan Y; Zhao J; Xu X; Nie Z; Zhang J
    CNS Neurosci Ther; 2023 Jan; 29(1):445-457. PubMed ID: 36253925
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of levofloxacin induced anaphylaxis and acute delirium in a palliative care setting.
    Ghoshal A; Damani A; Salins N; Deodhar J; Muckaden MA
    Indian J Palliat Care; 2015; 21(1):76-8. PubMed ID: 25709191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lack of nephrotoxic effects of the new quinolone antibacterial agent levofloxacin in rabbits.
    Inage F; Kato M; Yoshida M; Akahane K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):395-7. PubMed ID: 1622439
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction of the new quinolone antibacterial agent levofloxacin with fenbufen in mice.
    Furuhama K; Akahane K; Tawara K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):406-8. PubMed ID: 1622442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acute oral toxicity of the new quinolone antibacterial agent levofloxacin in mice, rats and monkeys.
    Kato M; Furuhama K; Yoshida M; Akahane K; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):365-6. PubMed ID: 1622433
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phototoxic potential of the new quinolone antibacterial agent levofloxacin in mice.
    Wagai N; Yoshida M; Takayama S
    Arzneimittelforschung; 1992 Mar; 43(3A):404-5. PubMed ID: 1622441
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Levofloxacin, a new quinolone antibacterial agent. An introductory overview.
    Hayakawa I; Furuhama K; Takayama S; Osada Y
    Arzneimittelforschung; 1992 Mar; 43(3A):363-4. PubMed ID: 1622431
    [No Abstract]   [Full Text] [Related]  

  • 50. [Levofloxacin].
    Azanza JR; Sádaba B; Quetglas EG; Escolar M
    Rev Med Univ Navarra; 1998; 42(4):220-5. PubMed ID: 10420933
    [No Abstract]   [Full Text] [Related]  

  • 51. [Levofloxacin (Tavanic)--a novel quinolone of the III generation. Antimicrobial activity, pharmacokinetics, clinical significance].
    Budanov SV; Smirnova LB
    Antibiot Khimioter; 2001; 46(5):31-8. PubMed ID: 11558453
    [No Abstract]   [Full Text] [Related]  

  • 52. Levofloxacin, a second-generation fluoroquinolone.
    North DS; Fish DN; Redington JJ
    Pharmacotherapy; 1998; 18(5):915-35. PubMed ID: 9758306
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [[New antimicrobial agent series XLVII]: levofloxacin].
    Saito A
    Jpn J Antibiot; 1994 Apr; 47(4):309-32. PubMed ID: 8201762
    [No Abstract]   [Full Text] [Related]  

  • 54. [Fleroxacin--a new quinolone antibiotic].
    Kostić D
    Vojnosanit Pregl; 1996; 53(4):311-24. PubMed ID: 9229948
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.